Cyclosporine excretion into breast milk

Myla E. Moretti, Michael Sgro, David W. Johnson, Reg S. Sauve, Mary J. Woolgar, Anna Taddio, Zul Verjee, Esther Giesbrecht, Gideon Koren, Shinya Ito

Research output: Contribution to journalArticlepeer-review

134 Scopus citations

Abstract

Although many female patients of childbearing age who are receiving cyclosporine have successful pregnancies, these women may be advised not to breast-feed. During recent years, cases of uneventful pregnancies and subsequent successful breast-feeding have been reported in the literature. The infant's blood cyclosporine concentration was usually very low. Based on these findings and the lack of detectable adverse effects, some investigators have suggested that women on cyclosporine may breast-feed, challenging the conventional view that cyclosporine is contraindicated during breast-feeding. Here, we report our experience with cyclosporine use during breast-feeding in five mother-infant pairs. We show a wide range of infant exposures to the drug in milk, noting that one of the infants had therapeutic blood concentrations of cyclosporine despite relatively low concentrations of the drug in milk.

Original languageEnglish
Pages (from-to)2144-2146
Number of pages3
JournalTransplantation
Volume75
Issue number12
DOIs
StatePublished - 27 Jun 2003
Externally publishedYes

Fingerprint

Dive into the research topics of 'Cyclosporine excretion into breast milk'. Together they form a unique fingerprint.

Cite this